These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3971402)

  • 1. [Substance-induced liver injury as a model for evaluating hepatoprotective drugs].
    Trcka V; Siblíková O
    Cas Lek Cesk; 1985 Feb; 124(6):161-4. PubMed ID: 3971402
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological and pathological studies on Taiwan folk medicine (IX): The hepatoprotective effect of the methanolic extract from echinops grijisii.
    Lin CC; Lin CH
    Am J Chin Med; 1993; 21(1):33-44. PubMed ID: 8328420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of serum glutamic oxaloacetic transaminase and bile acid levels for the detection of experimental liver injury in rats.
    Mihas AA; Gibson RG; Mihas TA; Hirschowitz BI
    J Med; 1981; 12(4):237-42. PubMed ID: 6947035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Picroliv affords protection against thioacetamide-induced hepatic damage in rats.
    Dwivedi Y; Rastogi R; Sharma SK; Garg NK; Dhawan BN
    Planta Med; 1991 Feb; 57(1):25-8. PubMed ID: 2062953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of serum cathepsin B-like activity in liver diseases].
    Miyata M
    Fukuoka Igaku Zasshi; 1988 Nov; 79(11):832-8. PubMed ID: 3250921
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of 4-phenyl-1,3-dithia-2-thioxo-cyclopent-4-ene on liver injury induced by repeated exposure to galactosamine plus carbon tetrachloride in rats.
    Sadanobu S; Takeuchi M; Tezuka M
    J Toxicol Sci; 1998 May; 23(2):129-48. PubMed ID: 9644653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aspartate and glutamate on carbon tetrachloride induced liver damage in rats.
    Singh J; Garg KN; Mehrotra GC
    Indian J Exp Biol; 1990 Dec; 28(12):1180-3. PubMed ID: 2099335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased alpha1-fetoprotein production in rat liver injuries induced by various hepatotoxins.
    Watanabe A; Miyazaki M; Taketa K
    Gan; 1976 Apr; 67(2):279-87. PubMed ID: 61145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late preventive effects on dimethylnitrosamine, thioacetamide or galactosamine-induced liver necrosis of the inhibitor of proteases, phenylmethylsulfonyl fluoride.
    de Ferreyra EC; de Fenos OM; Castro JA
    Res Commun Chem Pathol Pharmacol; 1983 Dec; 42(3):505-8. PubMed ID: 6665306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of carbon tetrachloride hepatotoxicity by hypoxia.
    Shibayama Y
    Br J Exp Pathol; 1986 Dec; 67(6):909-14. PubMed ID: 3801302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of putrescine on experimental acute hepatic injury in rats].
    Wu XM; Zhang BG; Zhou Q; Li BR
    Yao Xue Xue Bao; 1988 Mar; 23(3):161-7. PubMed ID: 3421104
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prostacyclin and other drugs protective against experimental liver damage in rats].
    Guo SH; Zhang DF; Zhou YX
    Zhonghua Nei Ke Za Zhi; 1986 Nov; 25(11):676-8, 702-3. PubMed ID: 3552493
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of tests of the hepatoprotective effect of silymarin in experimental animals].
    Siblíková O; Trcka V; Vakocová H; Tichý M
    Cas Lek Cesk; 1985 Feb; 124(6):165-9. PubMed ID: 3971403
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative studies on rat primary cultured and isolated hepatocytes in the evaluation of a therapeutic agents for liver disease.
    Sakamoto K; Tonooka M; Abe K; Usami K; Kasahara T
    Jpn J Pharmacol; 1986 Jul; 41(3):424-6. PubMed ID: 3761758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental models for the study of hepatoprotection.
    Fehér J; Pollák Z; Sréter L; Toncsev H; Cornides A; Gógl A; Vereckei A
    Acta Physiol Hung; 1984; 64(3-4):401-7. PubMed ID: 6532127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological and toxicological study of protexyl--a new hepatoprotective preparation].
    Klouchek E; Popov A; Uzunov P; Ovcharov R
    Eksp Med Morfol; 1988; 27(2):9-14. PubMed ID: 3168910
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparinoids - a new inhibitor of experimental liver necrosis in rats.
    Bartsokas SK; Papadimitriou DG; Papacharalampous NX; Katapoti Z; Kannas D
    Acta Hepatogastroenterol (Stuttg); 1974 Aug; 21(4):253-60. PubMed ID: 4141564
    [No Abstract]   [Full Text] [Related]  

  • 18. Antihepatotoxic activity of phenolic flavan-3-ols and their derivatives.
    Hsu FL; Tsai YJ; Kao MC; Chen CF
    Am J Chin Med; 1993; 21(1):45-50. PubMed ID: 8328421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental research on the hepatoprotective activity of drug combinations].
    Drenska D; Ovcharov R; Klouchek E; Popov A
    Eksp Med Morfol; 1985; 24(1):54-9. PubMed ID: 4029071
    [No Abstract]   [Full Text] [Related]  

  • 20. [Enzyme histochemical findings in the rat liver following galactosamine lesions and cholinorotate].
    Petzold H; Neupert A
    Z Gesamte Inn Med; 1972 Dec; 27(24):1087-90. PubMed ID: 4265973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.